Skeletal Muscle-Secreted DLPC Orchestrates Systemic Energy Homeostasis by Enhancing Adipose Browning

Xiaodi Hu,Mingwei Sun,Qian Chen,Yixia Zhao,Na Liang,Siyuan Wang,Pengbin Yin,Yuanping Yang,Sin Man Lam,Qianying Zhang,Alimujiang Tudiyusufu,Yingying Gu,Xin Wan,Meihong Chen,Hu Li,Xiaofei Zhang,Guanghou Shui,Suneng Fu,Licheng Zhang,Peifu Tang,Catherine C. L. Wong,Yong Zhang,Dahai Zhu

DOI: https://doi.org/10.1038/s41467-023-43402-z

IF: 16.6

2023-01-01

Nature Communications

Abstract:MyoD is a skeletal muscle-specifically expressed transcription factor and plays a critical role in regulating myogenesis during muscle development and regeneration. However, whether myofibers-expressed MyoD exerts its metabolic function in regulating whole body energy homeostasis in vivo remains largely unknown. Here, we report that genetic deletion of Myod in male mice enhances the oxidative metabolism of muscle and, intriguingly, renders the male mice resistant to high fat diet-induced obesity. By performing lipidomic analysis in muscle-conditioned medium and serum, we identify 1,2-dilinoleoyl-sn-glycero-3-phosphocholine (DLPC) as a muscle-released lipid that is responsible for MyoD-orchestrated body energy homeostasis in male Myod KO mice. Functionally, the administration of DLPC significantly ameliorates HFD-induced obesity in male mice. Mechanistically, DLPC is found to induce white adipose browning via lipid peroxidation-mediated p38 signaling in male mice. Collectively, our findings not only uncover a novel function of MyoD in controlling systemic energy homeostasis through the muscle-derived lipokine DLPC but also suggest that the DLPC might have clinical potential for treating obesity in humans.